$LUCD
Lucid Diagnostics Inc Stock $lucd

$lucd Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000149315224031168 Filed on August 12, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$1.200M	$1.000M
YoY Change	53.26%	528.93%
Cost Of Revenue		$1.614M
YoY Change		4.2%
Gross Profit		-$638.0K
YoY Change		-54.1%
Gross Profit Margin		-63.8%
Selling, General & Admin	$9.411M	$9.077M
YoY Change	15.37%	15.45%
% of Gross Profit
Research & Development	$1.666M	$1.372M
YoY Change	3.16%	-24.9%
% of Gross Profit
Depreciation & Amortization		$229.0K
YoY Change		-63.82%
% of Gross Profit
Operating Expenses	$12.87M	$12.17M
YoY Change	8.02%	3.62%
Operating Profit	-$11.69M	-$11.19M
YoY Change	5.09%	-3.38%
Interest Expense	$1.000K	$6.000K
YoY Change	-99.33%	-97.31%
% of Operating Profit
Other Income/Expense, Net	-$677.0K	$187.0K
YoY Change	-78.02%	-7.88%
Pretax Income	-$12.37M	-$11.01M
YoY Change	-12.93%	-3.3%
Income Tax
% Of Pretax Income
Net Earnings	-$12.37M	-$11.01M
YoY Change	-12.93%	-3.3%
Net Earnings / Revenue	-1030.92%	-1100.5%
Basic Earnings Per Share	-$0.25	-$0.23
Diluted Earnings Per Share	-$0.25	-$0.23
COMMON SHARES
Basic Shares Outstanding	53.99M shares	52.11M shares
Diluted Shares Outstanding	50.37M shares	48.21M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$24.92M
YoY Change		-23.49%
Cash & Equivalents	$14.49M	$24.92M
Short-Term Investments
Other Short-Term Assets		$2.184M
YoY Change		-30.53%
Inventory	$651.0K	$683.0K
Prepaid Expenses
Receivables	$39.00K	$160.0K
Other Receivables		$0.00
Total Short-Term Assets	$16.82M	$27.95M
YoY Change	-38.38%	-21.82%
LONG-TERM ASSETS
Property, Plant & Equipment	$940.0K	$1.050M
YoY Change	-26.79%	-24.41%
Goodwill
YoY Change
Intangibles	$842.0K	$947.0K
YoY Change	-56.35%	-61.11%
Long-Term Investments
YoY Change
Other Assets	$1.132M	$1.132M
YoY Change	-0.18%	5.01%
Total Long-Term Assets	$5.774M	$6.166M
YoY Change	-2.81%	-8.48%
TOTAL ASSETS
Total Short-Term Assets	$16.82M	$27.95M
Total Long-Term Assets	$5.774M	$6.166M
Total Assets	$22.60M	$34.11M
YoY Change	-32.02%	-19.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.135M	$903.0K
YoY Change	14.19%	41.76%
Accrued Expenses		$3.611M
YoY Change		-3.42%
Deferred Revenue
YoY Change
Short-Term Debt		$11.47M
YoY Change		-48.6%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$14.25M	$15.98M
YoY Change	-52.86%	-40.11%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities		$2.154M
YoY Change		194.26%
Total Long-Term Liabilities		$2.154M
YoY Change		194.26%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.25M	$15.98M
Total Long-Term Liabilities		$2.154M
Total Liabilities	$16.26M	$18.13M
YoY Change	-47.02%	-33.85%
SHAREHOLDERS EQUITY
Retained Earnings	-$192.2M	-$179.9M
YoY Change	37.39%	43.08%
Common Stock	$52.00K	$49.00K
YoY Change	23.81%	16.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.338M	$15.98M
YoY Change
Total Liabilities & Shareholders Equity	$22.60M	$34.11M
YoY Change	-32.02%	-19.71%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$12.37M	-$11.01M
YoY Change	-12.93%	-3.3%
Depreciation, Depletion And Amortization		$229.0K
YoY Change		-63.82%
Cash From Operating Activities		-$11.48M
YoY Change		63.75%
INVESTING ACTIVITIES
Capital Expenditures		$0.00
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		$0.00
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		11.63M
YoY Change		15410.67%
NET CHANGE
Cash From Operating Activities		-11.48M
Cash From Investing Activities		0.000
Cash From Financing Activities		11.63M
Net Change In Cash		151.0K
YoY Change		-102.17%
FREE CASH FLOW
Cash From Operating Activities		-$11.48M
Capital Expenditures		$0.00
Free Cash Flow		-$11.48M
YoY Change		63.4%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001799011
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
	LUCD	Loss On Issue Senior Secured Convertible Note LossOnIssueSeniorSecuredConvertibleNote		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	LUCD	Issue Common Stock Settle Termination Payment IssueCommonStockSettleTerminationPayment		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	LUCD	Proceeds Issuance Of Common Stock At The Market Facility ProceedsIssuanceOfCommonStockAtTheMarketFacility		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1016000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	952000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	913000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3444000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	406000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	3038000	usd
CY2024Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
CY2023Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
CY2024Q2	LUCD	Stock Issued During Period Value New Issuance Series B Preferred Stock StockIssuedDuringPeriodValueNewIssuanceSeriesBPreferredStock	11634000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	401000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-11005000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	15979000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-2311000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1850000	usd
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	285000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	2541000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	353000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5670000	usd
	LUCD	Stock Issued During Period Value New Exchange Series And Series A1 Preferred Stock StockIssuedDuringPeriodValueNewExchangeSeriesAndSeriesA1PreferredStock	-31791000	usd
	LUCD	Stock Issued During Period Value New Issuance Series B Preferred Stock StockIssuedDuringPeriodValueNewIssuanceSeriesBPreferredStock	55919000	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	4675000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	401000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-21617000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	15979000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	24906000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1165000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	234000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	147000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-11381000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	15071000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	23047000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	23047000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3982000	usd
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	625000	usd
	LUCD	Stock Issued During Period Value Asset Acquisitions Termination Payment StockIssuedDuringPeriodValueAssetAcquisitionsTerminationPayment	713000	usd
	LUCD	Stock Issued During Period Value At The Market Facility Net Of Deferred Financing Charges StockIssuedDuringPeriodValueAtTheMarketFacilityNetOfDeferredFinancingCharges	284000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	276000	usd
	LUCD	Stock Issued During Period Value New Issuance Series A Preferred Stock StockIssuedDuringPeriodValueNewIssuanceSeriesAPreferredStock	13625000	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	147000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-27628000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	15071000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	15071000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-21617000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-27628000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	730000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1245000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1850000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3982000	usd
	LUCD	Share Based Compensation Of Parent ShareBasedCompensationOfParent	285000	usd
	LUCD	Share Based Compensation Of Parent ShareBasedCompensationOfParent	625000	usd
	LUCD	Change In Fair Value Senior Secured Convertible Note ChangeInFairValueSeniorSecuredConvertibleNote	-890000	usd
	LUCD	Change In Fair Value Senior Secured Convertible Note ChangeInFairValueSeniorSecuredConvertibleNote	499000	usd
	LUCD	Loss On Issue Senior Secured Convertible Note LossOnIssueSeniorSecuredConvertibleNote	1111000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-681000	usd
	LUCD	Issue Common Stock Settle Termination Payment IssueCommonStockSettleTerminationPayment	713000	usd
	LUCD	Operating Expenses Settled With Amortization Of Common Stock OperatingExpensesSettledWithAmortizationOfCommonStock	113000	usd
	LUCD	Operating Expenses Settled With Amortization Of Common Stock OperatingExpensesSettledWithAmortizationOfCommonStock	23000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	115000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	18000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-625000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	1120000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-243000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-419000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1114000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1193000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-4399000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	5737000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-24094000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14057000	usd
	LUCD	Payments Of Purchase Of Equipment PaymentsOfPurchaseOfEquipment	37000	usd
	LUCD	Payments Of Purchase Of Equipment PaymentsOfPurchaseOfEquipment	32000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-37000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-32000	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	29798000	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	13625000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	10000000	usd
	LUCD	Proceeds Issuance Of Common Stock At The Market Facility ProceedsIssuanceOfCommonStockAtTheMarketFacility	284000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4000	usd
	LUCD	Proceeds From Issuance Of Common Stock One ProceedsFromIssuanceOfCommonStockOne	353000	usd
	LUCD	Proceeds From Issuance Of Common Stock One ProceedsFromIssuanceOfCommonStockOne	276000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	30155000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24185000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6024000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	10096000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	18896000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	22474000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	24920000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	32570000	usd
CY2024Q2	us-gaap	Revenues Revenues	1000000.0	usd
	us-gaap	Revenues Revenues	2000000.0	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-29100000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-24100000	usd
CY2024Q2	LUCD	Working Capital WorkingCapital	12000000.0	usd
CY2024Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	11200000	usd
CY2024Q2	us-gaap	Cash Cash	24900000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_842_eus-gaap--UseOfEstimates_zxyJB98Vrrg1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zXUc2fD1nI3l">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing the unaudited condensed consolidated financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and the determination of corresponding carrying value reserves, if any, and liabilities and the disclosure of contingent losses, as of the date of the unaudited condensed consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Significant estimates in these unaudited condensed consolidated financial statements include those related to the estimated fair value of debt obligations, stock-based equity awards and intangible assets. Other significant estimates include the estimated incremental borrowing rate, the provision or benefit for income taxes and the corresponding valuation allowance on deferred tax assets. Additionally, management’s assessment of the Company’s ability to continue as a going concern involves the estimation of the amount and timing of future cash inflows and outflows. On an ongoing basis, the Company evaluates its estimates and assumptions. The Company bases its estimates on historical experience and on various other assumptions believed to be reasonable. Due to inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_841_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z7zqaMxSATmc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zxWBrFlqwdbf">Reclassifications</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior-year amounts have been reclassified to conform to the current year presentation, which includes presenting costs of revenue within operating expenses on the statements of operations, in the unaudited condensed consolidated financial statements and accompanying notes to the unaudited condensed consolidated financial statements. The impact of the reclassifications made to prior year amounts is not material and did not affect net loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	976000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1977000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	159000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	605000	usd
CY2024Q2	LUCD	Operating Cost Of Revenue OperatingCostOfRevenue	1614000	usd
	LUCD	Operating Cost Of Revenue OperatingCostOfRevenue	3269000	usd
CY2023Q2	LUCD	Operating Cost Of Revenue OperatingCostOfRevenue	1549000	usd
	LUCD	Operating Cost Of Revenue OperatingCostOfRevenue	2887000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	9339000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	5000000	usd
	LUCD	Employee Retention Credit Benefits EmployeeRetentionCreditBenefits	913000	usd
	LUCD	On Behalf Of Obo Activities OnBehalfOfOBOActivities	341000	usd
	LUCD	Cash Payments CashPayments	-10652000	usd
	LUCD	Payment To Related Parties PaymentToRelatedParties	-4675000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	266000	usd
CY2024Q2	LUCD	Prepaid Service Providers And Suppliers PrepaidServiceProvidersAndSuppliers	563000	usd
CY2023Q4	LUCD	Prepaid Service Providers And Suppliers PrepaidServiceProvidersAndSuppliers	266000	usd
CY2024Q2	us-gaap	Prepaid Insurance PrepaidInsurance	266000	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	607000	usd
CY2024Q2	us-gaap	Security Deposit SecurityDeposit	1355000	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	1981000	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2184000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2854000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	2600000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	562000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1016000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	952000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	913000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3444000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	406000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	3038000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	598000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	583000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2285000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	321000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y3M29D
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M18D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.07875	pure
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.07875	pure
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3037000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1307000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	3038000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1305000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	884000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1106000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2154000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	199000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	598000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	583000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2285000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	321000	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M18D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.07875	pure
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3037000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	3038000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1305000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	884000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1106000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2154000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	199000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5305000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5305000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3881000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1424000	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	105000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	477000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1010000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5305000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5305000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4358000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3881000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	947000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1424000	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	105000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	505000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	477000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1010000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	210000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	421000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	316000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	947000	usd
CY2024Q2	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	11200000	usd
CY2023Q4	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	13950000	usd
CY2024Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	9811000	usd
CY2024Q2	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	11200000	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	11019000	usd
CY2023Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	13950000	usd
CY2023Q1	us-gaap	Debt Conversion Original Debt Interest Rate Of Debt DebtConversionOriginalDebtInterestRateOfDebt	0.825	pure
CY2023Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.30
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5504383	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.00
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	210000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	421000	usd
CY2024Q2	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	11200000	usd
CY2023Q4	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	13950000	usd
CY2024Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	9811000	usd
CY2024Q2	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	11200000	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	11019000	usd
CY2023Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	13950000	usd
CY2023Q1	us-gaap	Debt Conversion Original Debt Interest Rate Of Debt DebtConversionOriginalDebtInterestRateOfDebt	0.825	pure
CY2023Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.30
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y6M
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	765000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3519000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.23
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3333	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.31
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	275424	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.63
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8744626	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.70
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y7M6D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	199000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	3082590	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	2.26
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y3M18D
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	199000	usd
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1201000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1399000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2135000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4607000	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y6M
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	765000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3519000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.23
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3333	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.31
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	275424	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.63
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8744626	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.70
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y7M6D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	199000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	3082590	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	2.26
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y3M18D
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	199000	usd
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1201000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1399000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2135000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4607000	usd
CY2024Q1	LUCD	Fair Value Of Series B Preferred Stock Issued Shares FairValueOfSeriesBPreferredStockIssuedShares	44285000	shares
CY2024Q1	LUCD	Fair Value Of Series B Preferred Stock Issued FairValueOfSeriesBPreferredStockIssued	44285000	usd
CY2024Q1	LUCD	Less Fair Value Related To Newly Issued Series B Preferred Stock Shares LessFairValueRelatedToNewlyIssuedSeriesBPreferredStockShares	12495000	shares
CY2024Q1	LUCD	Less Fair Value Related To Newly Issued Series B Preferred Stock LessFairValueRelatedToNewlyIssuedSeriesBPreferredStock	12495000	usd
CY2024Q1	LUCD	Less Carrying Value Related To Series And Series A1 Preferred Stock Exchanged For Series B Preferred Stock Shares LessCarryingValueRelatedToSeriesAndSeriesA1PreferredStockExchangedForSeriesBPreferredStockShares	24295000	shares
CY2024Q1	LUCD	Less Carrying Value Related To Series And Series A1 Preferred Stock Exchanged For Series B Preferred Stock LessCarryingValueRelatedToSeriesAndSeriesA1PreferredStockExchangedForSeriesBPreferredStock	24294000	usd
CY2024Q1	LUCD	Deemed Dividend Charged To Accumulated Deficit DeemedDividendChargedToAccumulatedDeficit	7496000	usd
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49344945	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49344945	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	42329864	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	42329864	shares
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-11381000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-21617000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-27628000	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	7496000	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11005000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11381000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-29113000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-27628000	usd
CY2024Q1	LUCD	Fair Value Of Series B Preferred Stock Issued Shares FairValueOfSeriesBPreferredStockIssuedShares	44285000	shares
CY2024Q1	LUCD	Fair Value Of Series B Preferred Stock Issued FairValueOfSeriesBPreferredStockIssued	44285000	usd
CY2024Q1	LUCD	Less Fair Value Related To Newly Issued Series B Preferred Stock Shares LessFairValueRelatedToNewlyIssuedSeriesBPreferredStockShares	12495000	shares
CY2024Q1	LUCD	Less Fair Value Related To Newly Issued Series B Preferred Stock LessFairValueRelatedToNewlyIssuedSeriesBPreferredStock	12495000	usd
CY2024Q1	LUCD	Less Carrying Value Related To Series And Series A1 Preferred Stock Exchanged For Series B Preferred Stock Shares LessCarryingValueRelatedToSeriesAndSeriesA1PreferredStockExchangedForSeriesBPreferredStockShares	24295000	shares
CY2024Q1	LUCD	Less Carrying Value Related To Series And Series A1 Preferred Stock Exchanged For Series B Preferred Stock LessCarryingValueRelatedToSeriesAndSeriesA1PreferredStockExchangedForSeriesBPreferredStock	24294000	usd
CY2024Q1	LUCD	Deemed Dividend Charged To Accumulated Deficit DeemedDividendChargedToAccumulatedDeficit	7496000	usd
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49344945	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49344945	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	42329864	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	42329864	shares
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-11005000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-11381000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-21617000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-27628000	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	7496000	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11005000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11381000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-29113000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-27628000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48212040	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41833823	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46613362	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46613362	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41404547	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41404547	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48212040	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48212040	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41833823	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41833823	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46613362	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46613362	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41404547	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.62
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.62
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.67
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.67
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	64324444	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20517912	shares
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.62
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.62
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.67
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.67
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	64324444	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20517912	shares
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001493152-24-031168-index-headers.html	Edgar Link	pending
0001493152-24-031168-index.html	Edgar Link	pending
0001493152-24-031168.txt	Edgar Link	pending
0001493152-24-031168-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
ex10-2.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
lucd-20240630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
lucd-20240630_cal.xml	Edgar Link	unprocessable
lucd-20240630_def.xml	Edgar Link	unprocessable
lucd-20240630_lab.xml	Edgar Link	unprocessable
lucd-20240630_pre.xml	Edgar Link	unprocessable
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LUCD
Lucid Diagnostics Inc Stock $lucd

2024 Q3 Form 10-Q Financial Statement

#000149315224031168 Filed on August 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LUCD Lucid Diagnostics Inc Stock $lucd

2024 Q3 Form 10-Q Financial Statement

#000149315224031168 Filed on August 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LUCD
Lucid Diagnostics Inc Stock $lucd